Detect
The system detects signals that suggest infection, tissue damage, barrier breach, altered self, or stress.
Education First
Site section 6 of 12A research-first mini-course on triggers, vascular gates, immune-cell recruitment, NF-kB/MAPK signaling, inflammasomes, tissue patterns, resolution, chronic loops, measurement, and catalog-context sequence documentation.
Learning progress
Progress is private to this browser.
Inflammation cascade model
How a trigger propagates through the acute inflammation cascade and why the balance of loop gain against resolution, not duration alone, decides whether it resolves or turns chronic.
Outcome
resolves
the sign of the net loop gain
Net loop gain
−0.23
load × G 0.72 minus brake 0.95
Threshold load t_c
0.53of ceiling
k / G; above it zero activity is unstable
Fixed point x*
0.00of ceiling
zero activity is the stable state
Recruitment, the loop seed
0.36of ceiling
0.9 × the trigger load
Loop activity after 23 cycles
0.00of ceiling
Resolves toward homeostasis
With a trigger load of 0.40 and pro-resolving signals present, the loop drive load × G (0.72) does not exceed the brake k (0.95): the net gain is −0.23 and the load does not exceed the threshold t_c = k / G = 0.53. Zero activity is the only stable state, so the cascade resolves toward homeostasis; seeded at 0.36, it reads 0.00 of the ceiling after 23 cycles. The signal is at stage 5 of 5, Outcome: the loop either resolves or sustains itself.
Stage 5 of 5, Outcome. Trigger load 0.40; pro-resolving signals present; net loop gain −0.23; threshold load 0.53; fixed point 0.00. The cascade resolves toward homeostasis.
x(n+1) = x(n) + load × G × x(n) × (1 − x(n)) − k × x(n); G = 1.8; k = 0.95 with signals present, 0.25 absent; threshold t_c = k / G; fixed point x* = 1 − k / (load × G) above t_c
What it shows: A logistic feed-forward loop with one brake. Recruitment seeds the loop, the loop gain G amplifies activity, and the brake k drains it. The sign of load × G minus k is the one gate: at or below zero only zero activity is stable and the cascade resolves; above it zero becomes unstable and activity settles at x*, a transcritical bifurcation at t_c.
How to read it: The spine shows the stage the signal has reached and each stage’s propagated activity as a bar; the middle plot iterates the loop over cycles with x* dashed; the lower inset draws x* against the trigger load, the zero branch solid where stable and dashed where unstable, with the current load marked. The outcome is the same at every stage because it follows from the net gain alone.
Assumptions: Vascular permeability equals the trigger load; recruitment is 0.9 of permeability and seeds the loop; the cytokine bar is the loop activity after 23 cycles. All values are fractions of the model’s own ceiling. Real resolution is an active program of many mediators; one brake constant stands in for it.
A five-stage spine with a signal token at the current stage and a bar under each of the first four stages showing propagated activity, above a plot of cascade activity against cycles that either decays to zero or settles at the dashed fixed point, and an inset of the fixed point against the trigger load that stays at zero up to the threshold and rises after it, with the current load marked.
Check yourself
A learner sees cytokines, immune cells, and tissue change and wants a clinical conclusion. The course has to route that impulse back through trigger category, tissue context, timing, readout, and limitation.
Choose the next move
Pick an answer to see why.
Course spine
The course moves from the reason inflammation exists to the machinery that starts it, amplifies it, resolves it, or turns it into a chronic loop. Catalog context comes only after the system is mapped.
01 / Orientation
Define inflammation as a protective response that becomes risky when it cannot resolve.
02 / Triggers
Distinguish PAMPs, DAMPs, sterile injury, allergens, adaptive recognition, and metabolic stress as different entry signals.
03 / Vascular phase
Explain how blood vessels become a temporary gate for plasma proteins and leukocytes.
04 / Cellular phase
Place tissue sentinels, neutrophils, macrophages, dendritic cells, T cells, and B cells in sequence.
05 / Signaling phase
Trace receptor signaling through NF-kB/MAPK, cytokines, chemokines, NLRP3, IL-1beta, IL-18, TNF, and IL-6.
06 / Pattern atlas
Read acute, chronic, sterile, infectious, allergic/type-2, autoimmune/adaptive, metabolic, neuroinflammatory, and fibrotic patterns as research patterns.
07 / Tissue atlas
Compare how gut, lung, skin, connective tissue, vascular wall, adipose/liver, and brain constrain the same inflammatory logic.
08 / Resolution
Describe efferocytosis, macrophage state changes, lipid mediator class switching, tissue repair, and return toward homeostasis.
09 / Measurement
Match research readouts to what each can and cannot prove.
10 / Catalog bridge
Separate local catalog sequence documentation from biological claims and use guidance.
11 / Capstone
Assemble a full map from trigger to resolution or to a chronic feedback loop.
Chapter 01
Define inflammation as a protective response that becomes risky when it cannot resolve.
The system detects signals that suggest infection, tissue damage, barrier breach, altered self, or stress.
Vascular, cellular, and molecular programs concentrate plasma proteins and leukocytes where the signal began.
A complete response includes resolution machinery. Without an exit, protective logic can become tissue burden.
Chapter 02
Distinguish PAMPs, DAMPs, sterile injury, allergens, adaptive recognition, and metabolic stress as different entry signals.
Microbe-associated molecular motifs can be recognized by pattern-recognition receptors on sentinel cells and barrier tissues.
Intracellular or matrix-derived signals can appear after cellular stress, necrosis, mechanical disruption, or barrier damage.
Tissue disruption can initiate inflammation without a replicating pathogen, often through debris, crystals, ATP, or altered matrix.
Barrier alarmins, mast cells, IgE-linked recognition, eosinophils, and type-2 cytokines can create a distinct pattern.
T cells, B cells, antibodies, and antigen presentation can sustain loops that are driven by adaptive recognition.
Lipid stress, hypoxia, nutrient excess, and organelle stress can bias tissue-resident immune programs toward low-grade signaling.
Chapter 03
Explain how blood vessels become a temporary gate for plasma proteins and leukocytes.
Gate 01
Small vessels widen so flow and plasma access change at the local site.
Gate 02
Endothelial junction behavior shifts, allowing fluid and plasma proteins to enter tissue space.
Gate 03
Selectin-like rolling, chemokine presentation, integrin activation, and firm adhesion slow leukocytes under flow.
Gate 04
Complement, clotting, platelets, and fibrin context can overlap with inflammatory vascular biology.
Chapter 04
Place tissue sentinels, neutrophils, macrophages, dendritic cells, T cells, and B cells in sequence.
Macrophages, dendritic cells, mast cells, epithelial cells, stromal cells, and endothelial cells sense local change before many circulating cells arrive.
Granule release can rapidly alter vessels and barrier tissues, especially in allergic and type-2 settings.
Fast recruited cells that move along chemokine gradients, carry antimicrobial systems, and later become resolution cargo if they undergo apoptosis.
Phagocytose debris, coordinate cytokine output, interpret tissue state, and can shift toward pro-resolving repair programs.
Sample material, process antigen-like context, and connect innate sensing to adaptive immune interpretation.
Adaptive cells can refine, remember, amplify, or sustain inflammatory patterns depending on antigen context and tissue cues.
Chapter 05
Trace receptor signaling through NF-kB/MAPK, cytokines, chemokines, NLRP3, IL-1beta, IL-18, TNF, and IL-6.
Chapter 06
Read acute, chronic, sterile, infectious, allergic/type-2, autoimmune/adaptive, metabolic, neuroinflammatory, and fibrotic patterns as research patterns.
Fast onset, vascular gate, neutrophil-rich early phase, and a built-in expectation of resolution.
Persistent stimulus or failed clearance shifts the system toward macrophage, lymphocyte, and stromal feedback.
Damage signals, crystals, ischemic context, or matrix disruption can trigger inflammation without microbial replication.
PAMP recognition, complement, phagocytes, antigen presentation, and antimicrobial programs dominate interpretation.
Barrier alarmins, mast cells, IgE context, eosinophils, and IL-4/IL-5/IL-13-like circuits shape the pattern.
Antigen presentation, T-cell help, B-cell output, and memory-like reinforcement can sustain adaptive loops.
Adipose, liver, lipid, hypoxia, organelle, and nutrient-stress cues can generate slower innate-stromal tone.
Microglia, astrocytes, endothelial barriers, and immune entry constraints make the brain a special compartment.
Macrophage-stromal crosstalk, persistent particles, dense ECM, and compartmentalized immune clusters change tissue structure.
Chapter 07
Compare how gut, lung, skin, connective tissue, vascular wall, adipose/liver, and brain constrain the same inflammatory logic.
Barrier mucus, epithelium, microbiome-facing sampling, resident macrophages, dendritic cells, and lymphoid structures define the local rules.
Air-liquid interface, alveolar macrophages, vascular exposure, surfactant context, and rapid gas-exchange constraints shape the response.
Layered barrier, keratinocytes, Langerhans-like sentinels, mast cells, and mechanical exposure create a dense perimeter system.
Synovial-like lining, fibroblasts, matrix turnover, vessels, and mechanical stress can sustain stromal-immune feedback.
Endothelium, smooth muscle, platelets, complement/coagulation context, and macrophage lipid handling make the vessel a signaling surface.
Metabolic flux, lipid storage, hepatocyte and adipocyte stress, Kupffer-like cells, and macrophage niches bias low-grade signaling.
Blood-brain barrier, microglia, astrocytes, perivascular spaces, and limited immune traffic make measurement and interpretation distinct.
Chapter 08
Describe efferocytosis, macrophage state changes, lipid mediator class switching, tissue repair, and return toward homeostasis.
Resolution 01
Chemokine tone and adhesion cues fade so new leukocyte entry slows.
Resolution 02
Macrophages engulf apoptotic neutrophils and other dying cells before secondary necrosis increases local danger signals.
Resolution 03
Macrophage programs can shift away from amplification toward debris clearance, matrix coordination, and repair support.
Resolution 04
Eicosanoid and specialized pro-resolving mediator profiles change over time, helping convert inflammation from entry to exit.
Resolution 05
Stromal, epithelial, endothelial, and matrix programs rebuild local architecture without implying a product effect.
Resolution 06
The endpoint is not zero immune activity. It is restored surveillance with fewer alarm signals and less tissue disruption.
Unresolved loop
When triggers persist, clearance fails, or tissue remodeling becomes a new signal, the same protective machinery can settle into a self-reinforcing loop. This is a systems concept, not a diagnosis.
Chapter 09
Match research readouts to what each can and cannot prove.
Can show: Localize cells, tissue architecture, edema, vessel changes, matrix, and marker expression in space.
Cannot prove alone: By itself, prove a cause, timing sequence, clinical state, or product effect.
Can show: Quantify cell populations, activation markers, intracellular cytokines, and subset composition.
Cannot prove alone: Preserve full tissue architecture or prove that measured cells caused the tissue state.
Can show: Measure soluble mediator concentrations across samples, time points, or experimental groups.
Cannot prove alone: Identify the exact producing cell, tissue compartment, receptor engagement, or direction of causality alone.
Can show: Capture systemic acute-phase context and broad inflammatory tone.
Cannot prove alone: Specify tissue source, mechanism, diagnosis, or intervention outcome without other evidence.
Can show: Resolve gene programs, cell states, rare populations, and tissue-specific signatures.
Cannot prove alone: Automatically prove protein abundance, secreted mediator activity, or functional effect.
Can show: Profile mediator classes, complement/coagulation proteins, metabolites, and lipid mediator transitions.
Cannot prove alone: Replace controlled functional assays or establish safety, efficacy, or use guidance.
Chapter 10
Separate local catalog sequence documentation from biological claims and use guidance.
The entries below are kept apart from the biology chapters. Each shows a catalog sequence record and the receptor or structure family it relates to: identity and documentation only. No entry makes an immune, tissue, therapeutic, diagnostic, dosing, or human-use claim.
Stored sequence identity, related to the Toll-like receptor family taught in the signaling chapter.
Sequence record: Thymosin Alpha-1A copper-complex sequence record, related to copper transporter-system structure.
Sequence record: GHK-CuRelated to MC1R, a class A receptor. Shown as receptor-family structure, not as a claim about inflammatory state.
Related to the P2X7 ion-channel receptor. Shown as receptor structure beside the sequence identity only.
Related to immune surface-marker structure. Shown apart from the biology chapters and their claims.
Chapter 11
Assemble a full map from trigger to resolution or to a chronic feedback loop.
These sources support the biology and measurement framework. They are not cited as evidence for any catalog material producing a biological outcome.
Educational biology context only; not medical advice, diagnostic evidence, treatment guidance, dosing guidance, or evidence that any catalog item changes a biological outcome. Catalog materials appear only after the biological machinery is taught and are framed as research-context chemical sequence documentation.
Editorial scope: chemical identity, experimental context, analytical methods, source quality and regulatory boundaries. Source references and stated limitations form part of the material; they should remain attached to quotations or summaries.
Biological systems path
Why it matters
Greater transparency today drives better research tomorrow. We provide the materials and the data so the next breakthrough is one step closer.
Our mission